Sign in
Active, not recruitingNo phase

Study of Near-Infrared Imaging With Indocyanine Green for Detection of Sentinel Lymph Nodes in People With Vulvar Cancer

Key facts

Who runs it
Memorial Sloan Kettering Cancer Center
Where
Basking Ridge, Commack, Harrison, Houston, Middletown, Montvale, New York, and Uniondale, United StatesSee the 8 sites
Trial code
Status
Active, not recruiting
People taking part
22 people enrolled
Started
6 Nov 2023
Expected to end
Nov 2027
Type of study
Interventional
Treatments tested
  • ICG guided sentinel lymph node biopsy
Record updated
6 November 2026

Who can take part

Age
18 years and older
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • ≥18 years of age
  • Newly diagnosed with vulvar cancer and scheduled to undergo SLN biopsy (patients with squamous cell carcinomas and melanomas will be included)
  • Primary tumor ≤4 cm in size
  • For patients with squamous cell carcinoma, >1 mm of invasion is required

Who cannot take part

  • Clinically or radiographically enlarged inguinofemoral lymph nodes (if imaging is performed)
  • Presence of distant metastases
  • Absolute contraindication to radiocolloid Tc-99 or ICG
  • Nonsquamous or nonmelanoma histologic subtype

Where in United States

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)Basking Ridge, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities)Commack, United States
  • Memorial Sloan Kettering Westchester (Limited Protocol Activities)Harrison, United States
  • Houston Methodist Cancer Center (Data Collection Only)Houston, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities)Middletown, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities)Montvale, United States
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities)New York, United States
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities)Uniondale, United States

About the trial

What the trial wants to find out

The purpose of this study is to compare two types of imaging for sentinel lymph node (SLN) mapping in people with early-stage vulvar cancer. The researchers will compare indocyanine green near-infrared (ICG-NIR) imaging with lymphoscintigraphy. All participants in this study will be scheduled for standard surgical treatment at Memorial Sloan Kettering Cancer Center (MSK). This surgical treatment includes SLN mapping (with both lymphoscintigraphy and ICG-NIR imaging) and SLN biopsy.

The group in the trial

  • patients undergoing preoperative lymphoscintigraphyTreatment being tested

    Patients will undergo radiocolloid lymphoscintigraphy before their surgery; the surgeon will be blinded to the results of this procedure. The surgeon will subsequently inject ICG in accordance with the SLN protocol in the operating room and will identify and remove the SLN by use of near-infrared imaging guidance only.

    Treatment: ICG guided sentinel lymph node biopsy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
VISION (Vulvar ICG SLN Detection) Study: Near-Infrared Imaging With Indocyanine Green Injection for the Detection of Sentinel Lymph Nodes in Vulvar Cancer
Record updated
6 November 2026